Press Releases
Filters
August 23, 2024
Viatris Presents Late Breaking Abstract on Cenerimod at the 26th Asia-Pacific League of Associations for Rheumatology Annual Congress
July 3, 2024
Viatris Brings to Completion All Previously Announced Divestitures With the Closing of its Over-the-Counter Business Divestiture
July 2, 2024
U.S. Department of Justice Informs Viatris That It No Longer Considers Mylan a Subject of Generic Drug Industry Antitrust Investigation
June 26, 2024
Viatris Statement Regarding European Commission’s Approval for Proposed Divestiture of its Over-the-Counter Business to Cooper Consumer Health
June 4, 2024
Viatris to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
Displaying 61 - 70 of 184